- International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmun Rev. 2017 May;16(5):523-541
- Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection. J Hepatol. 2017 Jun;66(6):1282-1299
- Decreased serum DNase1-activity in patients with autoimmune liver diseases. Autoimmunity. 2017 Mar;50(2):125-132
- Seroprevalence of hepatitis E in HIV infected patients in Greece. J Med Virol. 2015 Sep;87(9):1517-20
- Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort. J Viral Hepat. 2015 Feb;22(2):120-7
- Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J Hepatol. 2013 Apr 27;5(4):160-9
- Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders. Eur J Gastroenterol Hepatol. 2012 Sep;24(9):1012-9
- Portopulmonary hypertension and serum endothelin levels in hospitalized patients with cirrhosis. Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):393-8
- Hepatic progenitor cells in chronic hepatitis C: a phenomenon of older age and advanced liver disease. Virchows Arch. 2010 Oct;457(4):457-66
- Acute-phase proteins as indicators of bacterial infection in patients with cirrhosis. Liver Int. 2009 Nov;29(10):1538-42.
- Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome. J Rheumatol. 2008 Oct;35(10):2012-6